04

  • Jay Bhattacharya, MD, PhD nominated as director of National Institutes of Health

    Stanford Medicine congratulates Stanford professor Jay Bhattacharya, MD, PhD, on his nomination to lead the National Institutes of Health.

  • Antiseizure drugs safe for pregnancy

    Six-year-olds who were exposed prenatally to common antiseizure medications had normal verbal and cognitive abilities, a large, multisite study has found.

  • Protecting heart cells from chemotherapy

    Researchers used a new screening technique to identify genes involved in heart cell damage during a common chemotherapy treatment. They also found a drug that may be able to prevent it.

  • Heart drug approved by FDA

    New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.

  • Brain malformations linked to protein misfolding

    Mutations in a complex that helps proteins fold correctly are tied to developmental disorders that include seizures and intellectual disability, Stanford Medicine-led research has found.

  • AI tool reads biopsy images

    Researchers used artificial intelligence to predict the activity of thousands of genes in tumors based on routinely collected images of tumor biopsies. It could guide treatment without costly genomic tests.

  • Stanford CME online program addition

    Stanford Medicine launches a pilot program collaboration to expand its CME courses to a broader audience worldwide, setting a new standard for online medical education.

  • CAR-T cells fight brain, spinal tumors

    CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a Stanford Medicine trial found.

  • Antibody composition shapes flu severity

    Why do some people develop severe flu symptoms? A Stanford Medicine study points the finger at an unsung portion of the antibodies our immune systems generate to fend off invading pathogens.

  • ecDNA catapults into spotlight

    Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings and potential therapies.